Clinical trial
Neuromuscular Magnetic Stimulation Counteracts Muscle Decline in ALS Patients
NCT03618966 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neuromuscular Magnetic Stimulation Counteracts Muscle Decline in ALS Patients
- Lead sponsor
- University of Roma La Sapienza
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 1, 2014
- Completion date
- November 1, 2017
- Enrollment
- 22 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.